Pancreatic cancer is on the rise in the United States, but there's another, less common type called pancreatic neuroendocrine ...

spleen and stomach in the two models checked for the various organs, Panc-1 and BxPC-3 models. Subcutaneous administration of SIL204 proved effective in reaching and treating pancreatic tumors and ...

pancreatic pseudocysts, and injury due to trauma. When the disease affects the splenic artery or vein, the adjacent spleen is often removed. After removal of the end of the pancreas, the remaining ...

(RTTNews) - Silexion Therapeutics (SLXN) announced positive data from preclinical studies of SIL204, its RNA interference (RNAi) therapy, in orthotopic pancreatic cancer models. These findings ...

Cell line-specific efficacy profiles: SIL204 showed robust activity across multiple pancreatic cancer ... intestine, spleen and stomach in the two models checked for the various organs, Panc ...